DME (drug)
DME, also known as 3,4-dimethoxy-β-hydroxyphenethylamine or as β-hydroxy-3,4-DMPEA, is a psychoactive drug of the phenethylamine and BOx families. It is the β-hydroxy derivative of 3,4-dimethoxyphenethylamine, which is an analogue of mescaline.
Use and effects
In his book PiHKAL, Alexander Shulgin lists DME's dose as greater than 115mg orally and its duration as unknown. At a dose of 115mg orally, its effects included faint nausea and possible alertness, but described as "substantially no effects".
Chemistry
Synthesis
The chemical synthesis of DME has been described.
Analogues
Analogues of DME include BOH and BOM, among others.
History
DME was first described in the scientific literature by Alexander Shulgin and colleagues in 1969. It was subsequently described in greater detail by Shulgin in his 1991 book PiHKAL.
Legal status
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.